Alveolar and serum cytokines in ventilator-associated pneumonia (VAP)

被引:0
|
作者
Allaouchiche, B [1 ]
Bobineau, I [1 ]
Coronel, B [1 ]
Tournadre, JP [1 ]
Chassard, D [1 ]
机构
[1] Hotel Dieu, Dept Anesthesie Reanimat, Lyon, France
关键词
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
A268
引用
收藏
页码:U195 / U195
页数:1
相关论文
共 50 条
  • [21] MORTALITY AND CAUSE OF DEATH IN VENTILATOR-ASSOCIATED PNEUMONIA (VAP) DUE TO PSEUDOMONAS
    CROUCH, S
    WUNDERINK, R
    JONES, C
    LEEPER, K
    MEDURI, G
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A99 - A99
  • [22] Compartmentalisation of cytokines and cytokine inhibitors in ventilator-associated pneumonia
    Julian L. Millo
    Marcus J. Schultz
    Conrad Williams
    Gerrit J. Weverling
    Timothy Ringrose
    Carolyn I. Mackinlay
    Tom van der Poll
    Christopher S. Garrard
    Intensive Care Medicine, 2004, 30 : 68 - 74
  • [23] Compartmentalisation of cytokines and cytokine inhibitors in ventilator-associated pneumonia
    Millo, JL
    Schultz, MJ
    Williams, C
    Weverling, GJ
    Ringrose, T
    Mackinlay, CI
    van der Poll, T
    Garrard, CS
    INTENSIVE CARE MEDICINE, 2004, 30 (01) : 68 - 74
  • [24] The function of probiotics on the treatment of ventilator-associated pneumonia (VAP): facts and gaps
    Karacaer, Feride
    Hamed, Imen
    Ozogul, Fatih
    Glew, Robert H.
    Ozcengiz, Dilek
    JOURNAL OF MEDICAL MICROBIOLOGY, 2017, 66 (09) : 1275 - 1285
  • [25] The Zap VAP Initiative: Empowering Staff to Eliminate Ventilator-Associated Pneumonia
    Yates, Andrea
    CRITICAL CARE NURSE, 2012, 32 (02) : E65 - E65
  • [26] Treatment of ventilator-associated pneumonia (VAP) due to multiresistant Acinetobacter baumannii
    Barrero-Almodovar, A
    Gallego-Lara, S
    Garnacho-Montero, J
    Ortiz-Leyba, C
    Jiménez-Jiménez, F
    Garcia-Garmendia, J
    INTENSIVE CARE MEDICINE, 2002, 28 : S191 - S191
  • [27] Ventilator-Associated Tracheobronchitis and Ventilator-Associated Pneumonia
    Kollef, Marin H.
    CHEST, 2013, 144 (01) : 3 - 5
  • [28] Ventilator-associated pneumonia (VAP) - Early and late-onset differences
    Dias, Margarida
    Marcal, Paulo
    Amaro, Piedade
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [29] Ventilator-associated pneumonia (VAP): Risk factors and outcome assessment.
    Sisson, JH
    Peterson, D
    Radkey, F
    Winfield, B
    Olsen, KM
    Patil, KD
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1998, 19 (09): : 699 - 699
  • [30] EFFICACY OF IMPLEMENTING A CARE BUNDLE TO PREVENT VENTILATOR-ASSOCIATED PNEUMONIA (VAP)
    Socias Mir, A.
    Gutierrez Madronal, L.
    Barcelo Planas, J.
    Rialp Cervera, G.
    Ibanez Lucia, P.
    INTENSIVE CARE MEDICINE, 2012, 38 : S212 - S213